ロード中...
A Current Perspective on Daptomycin for the Clinical Microbiologist
SUMMARY: Daptomycin is a lipopeptide antimicrobial with in vitro bactericidal activity against Gram-positive bacteria that was first approved for clinical use in 2004 in the United States. Since this time, significant data have emerged regarding the use of daptomycin for the treatment of serious inf...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2013
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3811228/ https://ncbi.nlm.nih.gov/pubmed/24092854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CMR.00030-13 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|